Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000706330 | SCV000835373 | uncertain significance | Neuronal ceroid lipofuscinosis 7 | 2022-07-11 | criteria provided, single submitter | clinical testing | This sequence change replaces arginine, which is basic and polar, with histidine, which is basic and polar, at codon 236 of the MFSD8 protein (p.Arg236His). This variant is present in population databases (rs371250204, gnomAD 0.004%). This missense change has been observed in individual(s) with developmental disorders (PMID: 32399599). ClinVar contains an entry for this variant (Variation ID: 582291). Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Tolerated"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0". The histidine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Breakthrough Genomics, |
RCV004692195 | SCV005190278 | uncertain significance | not provided | criteria provided, single submitter | not provided | ||
Natera, |
RCV001272737 | SCV001454995 | uncertain significance | Late-infantile neuronal ceroid lipofuscinosis | 2019-11-11 | no assertion criteria provided | clinical testing |